These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7169174)

  • 41. Characterization of the colorectal antigen IOR C2.II.
    Vázquez AM; Tormo B; Velandia A; Gómez CA; Alfonso M; Giscombe R; Ansotegui I; Jeddi-Tehrani M; Pérez R; Mellstedt H
    Year Immunol; 1993; 7():137-45. PubMed ID: 7690506
    [No Abstract]   [Full Text] [Related]  

  • 42. Novel antibodies as anticancer agents.
    Zafir-Lavie I; Michaeli Y; Reiter Y
    Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
    Peggs KS; Quezada SA; Korman AJ; Allison JP
    Curr Opin Immunol; 2006 Apr; 18(2):206-13. PubMed ID: 16464564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening of monoclonal immunoglobulins by immunofixation on cellulose acetate.
    Pizzolato MA
    Methods Enzymol; 1983; 92():220-227. PubMed ID: 6855612
    [No Abstract]   [Full Text] [Related]  

  • 45. Production and characterization of highly tumor-specific rat monoclonal antibodies recognizing the extracellular domain of human L-type amino-acid transporter 1.
    Ohno Y; Suda K; Masuko K; Yagi H; Hashimoto Y; Masuko T
    Cancer Sci; 2008 May; 99(5):1000-7. PubMed ID: 18294274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anticancer antibodies.
    Ross JS; Gray K; Gray GS; Worland PJ; Rolfe M
    Am J Clin Pathol; 2003 Apr; 119(4):472-85. PubMed ID: 12710120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immunofixation on cellulose acetate: value of its use in the laboratory].
    Chaker R; Bchini NH
    Arch Inst Pasteur Tunis; 1983; 60(1-2):43-8. PubMed ID: 6375607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens.
    Kuroki M; Shibaguchi H; Imakiire T; Uno K; Shirota K; Higuchi T; Shitama T; Yamada H; Hirose Y; Nagata A; Kuroki M
    Anticancer Res; 2003; 23(6a):4377-81. PubMed ID: 14666724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
    Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Gene's construction, expression and activity analysis of humanized single-domain antibody against human lung cancer].
    Wang JP; Zhuang GH; Yang GW; Wang Z; Li WZ; Xie LY; Yan JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):193-5, 199. PubMed ID: 16507257
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cellular and humoral immune responses of cancer patients to defined tumor antigens.
    Jäger D; Jäger E; Bert F; Knuth A
    Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025
    [No Abstract]   [Full Text] [Related]  

  • 52. Human monoclonal antibodies produced in transgenic BABkappa,lambda mice recognising idiotypic immunoglobulins of human lymphoma cells.
    Suárez E; Yáñez R; Barrios Y; Díaz-Espada F
    Mol Immunol; 2004 Jul; 41(5):519-26. PubMed ID: 15183930
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monoclonal immunoglobulins in HTLV III-positive sera.
    Sala PG; Mazzolini S; Tonutti E; Bramezza M
    Clin Chem; 1986 Mar; 32(3):574. PubMed ID: 3948425
    [No Abstract]   [Full Text] [Related]  

  • 54. [Analysis of tumor immunity with immune adherence reaction].
    Okada H
    Nihon Rinsho; 1979 May; 37(5):1065-70. PubMed ID: 470160
    [No Abstract]   [Full Text] [Related]  

  • 55. [Interview with Dr. M. Herlyn, Philadelphia. The new magic formula: monoclonal antibodies].
    Herlyn M
    MMW Munch Med Wochenschr; 1983 Jul; 125(29-30):16-18, 21. PubMed ID: 6413843
    [No Abstract]   [Full Text] [Related]  

  • 56. Recombinant globulins: novel research tools and possible pharmaceuticals.
    Hollenbaugh D; Chalupny NJ; Aruffo A
    Curr Opin Immunol; 1992 Apr; 4(2):216-9. PubMed ID: 1605911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal gammapathies. An attempt at a new classification.
    Radl J
    Neth J Med; 1985; 28(3):134-7. PubMed ID: 3982572
    [No Abstract]   [Full Text] [Related]  

  • 58. The dose-response curve in tumor-immunity.
    Prehn RT
    Int J Immunopharmacol; 1983; 5(4):255-7. PubMed ID: 6629588
    [No Abstract]   [Full Text] [Related]  

  • 59. Humoral effector mechanisms in the immunity to cancer.
    George AJ; Stevenson FK
    Immunol Today; 1990 Oct; 11(10):348-9. PubMed ID: 2222758
    [No Abstract]   [Full Text] [Related]  

  • 60. Monoclonal antibodies in the diagnosis and treatment of cancer.
    Med J Aust; 1981 May; 1(11):555-6. PubMed ID: 7254028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.